SEC Form 4 · accession 0001493152-26-035700
Beyond Air, Inc. · XAIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J Moorhead
Officer — Chief Financial Officer
Period of report
Jul 29, 2026
Accepted (ET)
Jul 31, 2026 · 6:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001641631
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 29, 2026 | P | 4,340 | $5.76 | A | 4,340 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A WarrantF3,F1,F2 | $5.51 | Jul 29, 2026 | P | 4,340 | A | — | — | Common Stock | 4,340 | 4,340 | D |
| Series B WarrantF3,F1,F4 | $5.51 | Jul 29, 2026 | P | 4,340 | A | — | — | Common Stock | 4,340 | 4,340 | D |
Explanation of responses
- F1Exercisable immediately upon issuance
- F2Expiration on the earlier of (i) the first anniversary of their issuance or (ii) the date that is 45 days following approval by the FDA of the Company's pending premarket approval supplement for LungFit PH II
- F3Each Series A Warrant and Series B Warrant was purchased together with one share of common stock for a combined purchase price of $5.76.
- F45 years following date of issuance